These agents are illegal and can contain harmful, undisclosed ingredients, including sibutramine which has been shown to increase the risk of heart attack and stroke
Typical Protocol: Commonly cited protocols use 1.5-1.6 mg subcutaneously two to three times per week (mirroring the Zadaxin regimen used in hepatitis trials), often run in 4 to 16 week cycles for general wellness use, with the original clinical trials using 1.6 mg twice weekly for 6 to 12 months
You get predictable, reliable dosing every single time
The UL for preformed vitamin A is set at 3,000 mcg for both men and women, including women who are pregnant or breastfeeding
Every document must consistently identify the material as intended for laboratory research, not for human administration
Peptide therapy requires evaluation by a licensed medical provider before starting any protocol